Clinical Trial Update: DM-CHOC-PEN for Brain Tumors in AYA Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update for DM-CHOC-PEN in adolescents and young adults with brain tumors, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Cancer

Drugs mentioned

• DM-CHOC-PEN (4-Demethyl-4-cholesteryloxycarbonylpenclome)

Snippet

Sponsor: DEKK-TEC, Inc. | Conditions: Advanced Cancer, Brain Metastases | Phase 2 | Status: COMPLETED